| Literature DB >> 35656797 |
Eva M Spoormans1, Jorrit S Lemkes1, Gladys N Janssens1, Ouissal Soultana1, Nina W van der Hoeven1, Lucia S D Jewbali2, Eric A Dubois2,3, Martijn Meuwissen4, Tom A Rijpstra5, Hans A Bosker6, Michiel J Blans7, Gabe B Bleeker8, Remon Baak9, Georgios J Vlachojannis10,11, Bob J W Eikemans12, Pim van der Harst11,13, Iwan C C van der Horst14,15, Michiel Voskuil11, Joris J van der Heijden16, Albertus Beishuizen17, Martin Stoel18, Cyril Camaro19, Hans van der Hoeven20, José P Henriques21, Alexander P J Vlaar22, Maarten A Vink23, Bas van den Bogaard24, Ton A C M Heestermans25, Wouter de Ruijter26, Thijs S R Delnoij15, Harry J G M Crijns27, Pranobe V Oemrawsingh28, Marcel T M Gosselink29, Koos Plomp30, Michael Magro31, Paul W G Elbers32, Peter M van de Ven33, Niels van Royen1,19.
Abstract
AIMS: ST-depression and T-wave inversion are frequently present on the post-resuscitation electrocardiogram (ECG). However, the prognostic value of ischaemic ECG patterns is unknown. METHODS ANDEntities:
Keywords: Cardiac arrest; ECG; Ischaemia; Left ventricular function; Shockable rhythm
Mesh:
Substances:
Year: 2022 PMID: 35656797 PMCID: PMC9302930 DOI: 10.1093/ehjacc/zuac060
Source DB: PubMed Journal: Eur Heart J Acute Cardiovasc Care ISSN: 2048-8726
Baseline characteristics
| Ischaemia on ECG ( | No ischaemia on ECG ( |
| |
|---|---|---|---|
| Age (years) | 66 ± 12 | 63 ± 15 | 0.003 |
| Sex (male) | 274 (80.6) | 126 (74.1) | 0.09 |
|
| |||
| Hypertension | 163 (48.4) | 78 (46.2) | 0.64 |
| Myocardial infarction | 101 (29.7) | 35 (20.6) | 0.03 |
| CABG | 46 (13.6) | 15 (8.8) | 0.12 |
| PCI | 74 (21.9) | 25 (14.7) | 0.054 |
| Coronary artery disease | 134 (39.4) | 47 (27.6) | 0.009 |
| CVA | 23 (6.8) | 8 (4.7) | 0.36 |
| Diabetes mellitus | 64 (18.9) | 29 (17.1) | 0.62 |
| Smoker | 75 (24.0) | 36 (22.8) | 0.78 |
| Hypercholesterolaemia | 95 (28.1) | 38 (22.6) | 0.19 |
| Peripheral artery disease | 24 (7.1) | 10 (5.9) | 0.61 |
|
| |||
| Witnessed arrest | 269 (79.1) | 129 (75.9) | 0.41 |
| Time from arrest to BLS (min) | 2 (1–5) | 2 (1–5) | 0.20 |
| Time from arrest to ROSC (min) | 15 (10–21) | 13 (7–20) | 0.07 |
| Time from arrest to ECG at ED (min) | 53 (39–71) | 49 (27–70) | 0.20 |
| Glasgow Coma Scale at admission | 3 (3–3) | 3 (3–3) | 0.97 |
|
| |||
| pH | 7.21 ± 0.14 | 7.23 ± 0.12 | 0.07 |
| Bicarbonate (mmol/L) | 19.1 ± 4.5 | 19.5 ± 4.2 | 0.45 |
| Base excess | −7.8 ± 6.4 | −7.2 ± 5.4 | 0.30 |
| Troponin-T (μg/L) | 0.058 (0.032–0.111) | 0.034 (0.022–0.075) | <0.001 |
| Creatinine-MB (μg/L) | 6.9 (4.1–22.9) | 4.9 (3.0–8.7) | 0.001 |
| Creatinine kinase (IU/L) | 164 (119–243) | 162 (105–284) | 0.85 |
| Lactate (mmol/L) | 5.2 (3.2–8.8) | 4.5 (2.8–8.2) | 0.20 |
| Creatinine (μmol/L) | 103 (88–118) | 99 (86–115) | 0.10 |
| Randomization to immediate CAG | 168 (49.4) | 94 (55.3) | 0.21 |
BLS, basic life support; CABG, coronary artery bypass grafting; CAG, coronary angiography; CVA, cerebrovascular accident; PCI, percutaneous coronary intervention; ROSC, return of spontaneous circulation.
Angiographic outcomes
| Ischaemia on ECG ( | No ischaemia on ECG ( | Odds ratio (95% CI)a | |
|---|---|---|---|
| Coronary angiography performed | 276 (81.2) | 139 (81.8) | 0.96 (0.60–1.55) |
| Urgent coronary angiography due to deterioration (in the delayed group) | 31 (9.1) | 4 (2.4) | 4.16 (1.45–12.00) |
| STEMI | 12/324 (3.7) | 1/167 (0.6) | 6.39 (0.82–49.53) |
| Cardiogenic shock | 1/324 (0.3) | 0 (0.0) | N.A. |
| Recurrent ventricular arrhythmias | 7/324 (2.2) | 3/166 (1.8) | 1.20 (0.31–4.70) |
| Other | 11/324 (3.4) | 3/167 (1.8) | 1.92 (0.53–6.98) |
| Significant coronary artery disease (>70%) | 186 (67.4) | 80 (57.6) | 1.52 (1.01–2.32) |
| Coronary artery disease severity | |||
| One-vessel disease | 70 (25.4) | 44 (31.7) | Reference |
| Two-vessel disease | 60 (21.7) | 22 (15.8) | 1.71 (0.93–3.18) |
| Three-vessel disease | 56 (20.3) | 14 (10.1) | 2.51 (1.28–5.04) |
| Acute unstable lesion | 40 (14.5) | 22 (15.8) | 0.90 (0.51–1.59) |
| Acute thrombotic occlusion | 16 (5.8) | 5 (3.6) | 1.65 (0.59–4.60) |
| Chronic total occlusion | 108 (39.1) | 38 (27.3) | 1.71 (1.10–2.67) |
| PCI | 95 (27.9) | 49 (28.8) | 0.96 (0.63–1.48) |
| CABG | 25 (7.4) | 13 (7.6) | 0.96 (0.48–1.92) |
| Conservative treatment | 222 (65.3) | 109 (64.1) | 1.05 (0.71–1.55) |
CABG, coronary artery bypass grafting; CI, confidence interval; NA, not applicable; PCI, percutaneous coronary intervention; STEMI, ST-elevation myocardial infarction.
Odds ratios are reported as effect estimates with 95% confidence intervals. No ischaemia was used as the reference group.
Clinical outcomes
| Ischaemia on ECG ( | No ischaemia on ECG ( | Effect size (+95% CI)[ | |
|---|---|---|---|
| Survival at 90 days follow-up | 212 (62.4) | 125 (73.5) | 1.51 (1.08–2.12) |
| Targeted temperature management | 314 (92.4) | 162 (95.3) | 0.60 (0.26–1.35) |
| Median target temperature | 34 (33–36) | 34 (33–36) | |
| Geometric mean (95% CI) | 34 (34–34) | 34 (34–34) | 1.00 (0.99–1.01) |
| Left ventricular ejection fraction[ | 44.7 ± 12.5 | 49.9 ± 13.3 | −5.13 (−8.84 to −1.42) |
| Noradrenaline administered | 303 (89.1) | 137 (80.6) | 1.97 (1.18–3.29) |
| Duration of administration (days) | 1.9 (1.2–2.9) | 1.6 (1.1–2.3) | |
| Geometric mean (95% CI) | 1.7 (1.5–1.9) | 1.5 (1.3–1.8) | 1.09 (0.90–1.32) |
| Dobutamine administered | 93 (27.4) | 42 (24.7) | 1.15 (0.75–1.75) |
| Duration of administration (days) | 1.2 (0.7–1.6) | 1.3 (0.8–1.8) | |
| Geometric mean (95% CI) | 1.0 (0.8–1.2) | 1.1 (0.8–1.5) | 0.91 (0.63–1.30) |
| Use of assist device | 4 (1.2) | 3 (1.8) | 0.66 (0.15–3.00) |
| Acute kidney injury[ | |||
| Stage 0 | Reference | ||
| Stage 1 | 16/307 (5.2) | 4/156 (2.6) | 2.06 (0.68–6.28) |
| Stage 2 | 5/307 (1.6) | 4/156 (2.6) | 0.64 (0.17–2.43) |
| Stage 3 | 14/307 (4.6) | 8/156 (5.1) | 0.90 (0.37–2.20) |
| Need for renal replacement therapy | 11 (3.2) | 5 (2.9) | 1.10 (0.38–3.23) |
| Recurrence of ventricular tachycardia needing defibrillation | 20 (5.9) | 13 (7.6) | 0.76 (0.37–1.56) |
| ICD implanted | 124 (36.5) | 81 (47.6) | 0.63 (0.43–0.92) |
| Maximum troponin value (μg/L) | 0.595 (0.243–1.430) | 0.359 (0.159–0.845) | |
| Geometric mean (95% CI) | 0.863 (0.660–1.129) | 0.413 (0.296–0.574) | 1.58 (1.13–2.20) |
| Maximum creatinine kinase MB (μg/L) | 39.1 (18.8–122.9) | 21.8 (12.7–47.5) | |
| Geometric mean (95% CI) | 46.4 (38.2–56.3) | 26.4 (21.1–33.1) | 1.80 (1.39–2.32) |
| Maximum creatinine kinase (IU/L) | 800 (379–2087) | 899 (361–1555) | |
| Geometric mean (95% CI) | 917 (773–1088) | 876 (690–1111) | 1.06 (0.86–1.31) |
| Maximum lactate (mmol/L) | 4.9 (2.8–8.4) | 4.5 (2.8–8.0) | |
| Geometric mean (95% CI) | 5.0 (4.51–5.50) | 4.5 (3.9–5.2) | 1.05 (0.92–1.19) |
| Duration of ICU hospitalization | 4 (2–6) | 3 (2–6) | |
| Geometric mean (95% CI) | 4 (4–5) | 4 (3–4) | 1.11 (0.97–1.29) |
| Duration of hospital admission | 12 (6–19) | 16 (7–22) | |
| Geometric mean (95% CI) | 11 (9–12) | 13 (11–15) | 0.83 (0.69–0.99) |
CI, confidence intervals; ICD, implantable cardioverter defibrillator; ICU, intensive care unit.
Effect sizes are expressed in hazard ratios for death, odds ratios, mean differences, and ratio of geometric means with 95% confidence intervals. No signs ischaemia on the ECG is used as the reference group.
Left ventricular function was assessed using CMR or echocardiography in 122 patients with ischaemic ECG patterns and in 75 patients that were without ischaemic ECG patterns.
Acute kidney injury classification ranges from 0 to 3, higher score indicating a higher stage of injury.
Assessment of potential confounders for association between ischaemic electrocardiogram and 90-day survival
| (Adjusted) HR for ischaemic ECG | 95% CI for (adjusted) HR for ischaemic ECG |
| |
|---|---|---|---|
| Ischaemic ECG (unadjusted HR) | 1.51 | 1.08–2.12 | 0.02 |
| Adjusted for single confounder | |||
| Age | 1.33 | 0.94–1.86 | 0.10 |
| Male sex | 1.53 | 1.09–2.16 | 0.01 |
| History of myocardial infarction | 1.45 | 1.03–2.04 | 0.03 |
| History of PCI | 1.46 | 1.04–2.05 | 0.03 |
| History of coronary artery disease | 1.45 | 1.03–2.04 | 0.03 |
| Time from OHCA to ROSC (min) | 1.36 | 0.93–2.00 | 0.12 |
Hazard ratios and adjusted hazard ratios for ischaemic ECG and 90-day survival.
HR, hazard ratio; OHCA, out-of-hospital cardiac arrest; PCI, percutaneous coronary intervention; ROSC, return of spontaneous circulation.